Investors Our investor proposition
GSK is a science-led global healthcare company that aims to deliver growth and improving returns to shareholders through the development of innovative pharmaceutical, vaccine and consumer healthcare products.
GSK investor event
We announced our second quarter 2017 results and hosted an investor event on 26 July. At the investor event Emma Walmsley, CEO, and Simon Dingemans, CFO, spoke about our key priorities and financial outlook.
Our new business priorities
At the investor event we set out our new business priorities - centred around Innovation, Performance and Trust - which we will implement from 2018 onwards.
See our new business priorities